Episurf Medical (Nasdaq: EPIS B) will attend Redeye Technology & Life Science Day which is held on December 3rd, 2024. The event is arranged by Redeye and Episurf will be represented by its CEO Pål Ryfors. The format will be a 2-minute pitch followed by a 16-minute Q&A session.

The presentation will be streamed live at 09:00 CET at: https://www.redeye.se/events/1038747/redeye-technology-life-science-day and will also be made available afterwards on our website www.episurf.com.

Location: Sergelkonferensen, Mäster Samuelsgatan 42 (Sveavägen 9), Stockholm.

CisionBlockPro\Cision\FeedItem Object
(
    [HtmlCompanyInformation:protected] => <p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><strong><span style="font-size:10pt">About Episurf Medical</span></strong></p>
<p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><em>Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.</em></p>
<p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><span style="font-family:arial,helvetica,sans-serif; font-size:10pt"><em>The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on 3 December 2024.</em></span></p>
    [HtmlContact:protected] => <p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><strong><span style="font-size: 10pt; font-family: arial,helvetica,sans-serif;">For more information, please contact:</span></strong></p>
<p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="font-size: 10pt;">P&aring;l Ryfors, CEO, Episurf Medical<br /></span><span style="font-size: 10pt; font-family: arial,helvetica,sans-serif;">Tel:</span><span style="font-size: 10pt;">+46 (0) 709 62 36 69<br /></span><span style="font-size: 10pt;">Email:&nbsp;</span><a href="mailto:pal.ryfors@episurf.com">pal.ryfors@episurf.com</a></p>
    [HtmlTitle:protected] => <h1 style="line-height:120%"><span style="font-family:arial,helvetica,sans-serif"><strong>Episurf Medical to present at Redeye Technology &amp; Life Science Day on December 3rd, 2024</strong></span></h1>
    [HtmlHeader:protected] => 
    [HtmlIntro:protected] => 
    [Body:protected] => Episurf Medical (Nasdaq: EPIS B) will attend Redeye Technology & Life Science Day which is held on December 3rd, 2024. The event is arranged by Redeye and Episurf will be represented by its CEO Pål Ryfors. The format will be a 2-minute pitch followed by a 16-minute Q&A session.
The presentation will be streamed live at 09:00 CET at: https://www.redeye.se/events/1038747/redeye-technology-life-science-day and will also be made available afterwards on our website www.episurf.com.
Location: Sergelkonferensen, Mäster Samuelsgatan 42 (Sveavägen 9), Stockholm.
    [HtmlBody:protected] => <p style="margin-bottom:11px;margin-top:12px"><span><span><span style="font-family:arial,helvetica,sans-serif"><span style="font-size:10pt"><span><span style="color:black">Episurf Medical (Nasdaq: EPIS B) will attend Redeye Technology &amp; Life Science Day which is held on December 3rd, 2024. The event is arranged by Redeye and Episurf will be represented by its CEO Pål Ryfors. The format will be a 2-minute pitch followed by a 16-minute Q&amp;A session.</span></span></span></span></span></span></p>
<p style="margin-bottom:11px"><span><span style="font-size:11pt"><span><span style="font-family:arial,helvetica,sans-serif"><span style="font-size:10pt"><span><span style="color:black">The presentation will be streamed live at <strong>09:00 CET</strong> at: <a href="https://www.redeye.se/events/1038747/redeye-technology-life-science-day" style="color:#0563c1; text-decoration:underline">https://www.redeye.se/events/1038747/redeye-technology-life-science-day</a> and will also be made available afterwards on our website </span></span></span><a href="https://www.episurf.com" style="color:#0563c1; text-decoration:underline"><span style="font-size:10pt"><span>www.episurf.com</span></span></a><span style="font-size:10pt"><span><span style="color:black">.</span></span></span></span></span></span></span></p>
<p style="margin-bottom:11px"><span><span style="font-size:11pt"><span><span style="font-family:arial,helvetica,sans-serif"><strong><span style="font-size:10pt"><span>Location</span></span></strong><span style="font-size:10pt"><span>: Sergelkonferensen, Mäster Samuelsgatan 42 (Sveavägen 9), Stockholm.</span></span></span></span></span></span></p>
    [ServiceCategories:protected] => Array
        (
            [0] => CisionBlockPro\Cision\ServiceCategory Object
                (
                    [ServiceName:protected] => Facebook
                    [Name:protected] => Facebook
                    [Value:protected] => 15927
                )
        )
    [LogoUrl:protected] => https://mb.cision.com/Public/14691/logo/96c29c854b230ac3_org.png
    [CompanyInformation:protected] => About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on 3 December 2024.
    [Contact:protected] => For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
    [Header:protected] => 
    [Keywords:protected] => Array
        (
            [0] => Episurf Medical
            [1] => EpiSurf
            [2] => Pål Ryfors
            [3] => Episealer
        )
    [QuickFacts:protected] => Array
        (
        )
    [Categories:protected] => Array
        (
        )
    [Videos:protected] => Array
        (
        )
    [Files:protected] => Array
        (
            [0] => CisionBlockPro\Cision\File Object
                (
                    [IsMain:protected] => 1
                    [MediaType:protected] => File
                    [Url:protected] => https://mb.cision.com/Main/14691/4074746/3146880.pdf
                    [FileName:protected] => wkr0006.pdf
                    [Title:protected] => Episurf Medical to present at Redeye Technology & Life Science Day on December 3rd, 2024
                    [Description:protected] => Episurf Medical to present at Redeye Technology & Life Science Day on December 3rd, 2024
                    [CreateDate:protected] => 2024-12-03T07:30:05.14Z
                    [Keywords:protected] => Array
                        (
                        )
                    [Extension:protected] => pdf
                )
        )
    [Quotes:protected] => Array
        (
        )
    [ExternalLinks:protected] => Array
        (
        )
    [EmbeddedItems:protected] => Array
        (
        )
    [Id:protected] => 4950200
    [EncryptedId:protected] => 46F692953FECBA9A
    [IsRegulatory:protected] => 
    [PublishDate:protected] => 2024-12-03T07:30:00Z
    [LastChangeDate:protected] => 2024-12-03T07:30:05.123Z
    [Title:protected] => Episurf Medical to present at Redeye Technology & Life Science Day on December 3rd, 2024
    [Intro:protected] => 
    [IptcCode:protected] => 04016003
    [InformationType:protected] => PRM
    [LanguageCode:protected] => en
    [CountryCode:protected] => se
    [CanonicalUrl:protected] => 
    [CisionWireUrl:protected] => https://news.cision.com/episurf/r/episurf-medical-to-present-at-redeye-technology---life-science-day-on-december-3rd--2024,c4074746
    [LanguageVersions:protected] => Array
        (
            [0] => CisionBlockPro\Cision\LanguageVersion Object
                (
                    [Code:protected] => sv
                    [ReleaseId:protected] => 4950205
                )
        )
    [Images:protected] => Array
        (
        )
    [Tickers:protected] => Array
        (
            [0] => stdClass Object
                (
                    [Symbol] => EPIS B
                    [ISIN] => SE0003491562
                    [PrimaryListing] => 1
                    [IsShare] => 1
                    [MarketPlaceSymbol] => STO
                    [MarketPlaceName] => Stockholmsbörsen
                    [MarketPlaceBloombergCode] => SS
                    [MarketPlaceMarketWireCode] => OMX
                    [MarketPlaceIsRegulated] => 1
                    [MarketPlaceCountryCode] => SE
                )
        )
)